Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Europe Viscosupplementation Market Outlook from (2023 to 2033)

The Europe viscosupplementation market size was projected to be US$ 4.49 billion in 2022. By the end of 2023, the market is likely to reach a valuation of US$ 4.91 billion. The market for Europe viscosupplementation is expected to garner a 9.37% CAGR and reach a market worth US$ 12.03 billion by 2033.

Key Market Trends and Highlights

  • Holistic wellness approach Some European wellness centers emphasize pain management and mental health, diet, and lifestyle changes as part of holistic wellness programs that represent a whole approach to joint health, including viscosupplementation.
  • Better quality of life When considering viscosupplementation therapies, European patients frequently prioritize enhancing their overall quality of life since the treatment provides pain relief and the capacity to live an active and satisfying lifestyle.
  • Diverse product portfolio A wide variety of viscosupplementation solutions, including hyaluronic acid formulations and injection schedules made to match the individual needs of patients, are available on the market, encouraging the use of individualized treatment plans.
Attributes Key insights
Estimated Market Value in 2022 US$ 4.49 billion
Expected Market Value in 2023 US$ 4.91 billion
Expected Market Value in 2033 US$ 12.03 billion
Value based CAGR from 2023 to 2033 9.37%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

Report Attributes Details
Market value in 2018 US$ 4.30 billion
Market value in 2022 US$ 4.49 billion
CAGR from 2018 to 2022 3.3%

During the historical period, 2018 to 2022, the Europe viscosupplementation market grew at a CAGR of 3.3%. Healthcare organizations and pharmaceutical businesses launched awareness campaigns and educational activities to enlighten patients and healthcare professionals about the advantages and availability of viscosupplementation therapy.

Product formulas have improved due to the ongoing research and development efforts by manufacturers, including the creation of viscosupplements with greater longevity and efficacy. Viscosupplementation therapies become more appealing to patients and doctors due to these advancements.

The market grew due to the increasing skill of orthopedic experts in giving viscosupplementation injections and incorporating them into comprehensive treatment strategies.

Europe Viscosupplementation Market Key Drivers

  • With increased recreational and competitive sports in Europe, joint problems and overuse conditions have become more common. Viscosupplementation therapies are becoming more and more popular among fitness enthusiasts and athletes as a way to relieve joint discomfort and keep up an active lifestyle.
  • Viscosupplementation therapies relieve pain and enhance the general quality of life for those with joint problems, promoting its use as a holistic therapy.
  • Patients and healthcare professionals are increasingly seeking non-opioid pain treatment choices due to worries about opioid abuse and addiction, making viscosupplementation a popular option.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Europe Viscosupplementation Market

  • It can be challenging and time-consuming to navigate the various regulatory procedures and secure approvals for viscosupplementation products throughout European nations.
  • It is crucial to show that viscosupplementation is effective and affordable compared to alternative therapies, including painkillers, physical therapy, and surgical techniques.
  • Price sensitivity amongst patients and healthcare professionals may prevent the widespread use of expensive viscosupplementation products, which would harm market expansion.
  • Viscosupplementation therapies may be more expensive or less accessible to patients in some European nations because of differences in insurance coverage and payment regulations.

Comparative View of Adjacent Markets

The table below has compared two other markets, namely global viscosupplementation market and russia viscosupplementation market below. This shows that how the Europe viscosupplementation market will perform in contrast to these two markets.

Europe Viscosupplementation Market:

CAGR from 2023 to 2033 9.37%
Market Value in 2023 US$ 4.91 billion
Key Trends
  • Knee osteoarthritis is becoming more common, which is driving demand for efficient treatment options.
  • Osteoarthritis is becoming more common, there is a robust healthcare system, and viscosupplementation market demand is on the rise.
Key Opportunities Intra-articular injections based on hyaluronic acid have emerged as one of the most popular options for treating symptomatic knee osteoarthritis.

Global Viscosupplementation Market:

CAGR from 2023 to 2033 4.2%
Market Value in 2023 US$ 2.06 billion
Key Trends
  • Increased research and development spending and growing osteoarthritis cases boosts demand for viscosupplementation equipment
  • As the aged are more vulnerable to musculoskeletal ailments like osteoarthritis, the expanding senior population throughout the world would accelerate the market growth during the anticipated period.
Key Opportunities
  • Viscosupplementation can be used in addition to orthopedic operations and joint surgeries to help with post-operative care as well as pain control.

Russia Viscosupplementation Market:

CAGR from 2023 to 2033 6%
Market Value in 2023 US$ 50.23 million
Key Trends
  • Viscosupplementation has become widely used in Russia due to improvements in orthopedic treatment.
  • The demand will also increase due to a growing pool of qualified orthopedic experts.
Key Opportunities
  • Russia has the possibility to become a popular destination for individuals seeking economical, high-quality healthcare, including viscosupplementation, from its surrounding nations.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country wise Insights

The table below lists the top five nations expected to experience prominent growth during the forecast period. The United Kingdom and France are predicted to have the most development among these nations.

Forecast CAGRs from 2023 to 2033

Countries CAGR from 2023 to 2033
The United Kingdom 9.8%
France 9.1%
Germany 8.2%
Spain 6.3%
Italy 5.7%

Advanced Healthcare Facilities to Enhance Sales in the United Kingdom

During the forecast period, the viscosupplementation market in the United Kingdom is expected to garner a 9.8% CAGR. The aging population in the United Kingdom and the rising incidence of osteoarthritis and other joint-related problems drives the need for viscosupplementation as a non-surgical therapy option.

Numerous viscosupplementation products have received regulatory approval in the United Kingdom, offering patients and medical professionals a variety of therapeutic alternatives.

The advanced healthcare system in the country, which includes specialist hospitals and clinics, makes it possible to administer viscosupplementation therapies effectively.

Rising Medical Tourism to Boost Demand in France

France market for viscosupplementation is likely to expand with a 9.1% CAGR from 2023 to 2033. Health tourism has taken up in the spa towns of France, known for their healing properties. Viscosupplementation therapies combined with pleasure and wellness activities draw patients from France and other countries to these cities, filling a distinct niche in the healthcare tourism industry.

In the field of medicine, France has a long history of research and invention. Government-sponsored research projects frequently investigate new viscosupplementation uses, formulations, and delivery techniques, expanding the range of therapeutic alternatives accessible to patients.

Top Notch Orthopedic Treatments to Accelerate Germany Market Growth

The Europe viscosupplementation market in Germany is likely to garner an 8.2% CAGR from 2023 to 2033. Patients from abroad seeking viscosupplementation along with other medical treatments are drawn to the well established health tourism sector of Germany. The country is a popular destination thanks to its advanced infrastructure and healthcare system.

In Germany, there is an increased prevalence of joint-related diseases such as osteoarthritis because of rising obesity rates. Germany is recognized for its orthopedic expertise and cutting-edge medical technology, which has increased demand for viscosupplementation for its minimally invasive treatment.

Government Encouragement towards Joint Health to Boost Growth in France

The Europe viscosupplementation market in Spain is anticipated to accelerate with a 6.3% CAGR during the forecast period. The favorable climate in Spain stimulates outdoor activities, rendering joint health a concern for its young population. This trend increases the demand for viscosupplementation among those who want to maintain an active lifestyle.

Like other European nations, Spain is undergoing a demographic change with a rise in older adults. This group frequently uses viscosupplementation to control joint discomfort and maintain mobility as they age. The private healthcare industry in Spain is vital in ensuring prompt access to viscosupplementation operations. Patients frequently seek therapy at private clinics if they need pain relief right away.

Focus on Overall Wellness to Bolster Demand in Italy

The Italy viscosupplementation market is poised to expand with a 5.7% CAGR during the forecast period. The importance of health and wellbeing in Italian culture is quite significant. Italian patients actively seek therapies like viscosupplementation to maintain joint health and lead active lives far into their senior years.

Viscosupplementation is a less invasive approach for treating osteoarthritis and associated problems, according to the highly qualified orthopedic specialists of Italy. The orthopedic expertise of the nation helps the market expand.

Category wise Insights

The table below highlights how the single injection viscosupplementation of Europe viscosupplementation market is projected to lead the regional market by product type. This segment is expected to garner an 8.2% CAGR during the forecast period.

The viscosupplementation demand in Europe has been gaining immense traction in the hospitals in the last few years. During the forecast period, the hospitals segment is likely to expand with a 7.9% CAGR.

Category CAGR from 2023 to 2033
Single Injection Viscosupplementation 8.2%
Hospitals 7.9%

Greater Relief and Reduced Discomfort to Boost the Sales of Single Injection

Since more people are becoming aware of the need to regenerate articular joint cartilage, the single injection segment is anticipated to have a leading position in the Europe viscosupplementation industry over the projected period.

Patients will feel less pain if they receive fewer shots. A single injection is a popular choice because of how straightforward and minimally uncomfortable it is for most people. Single-injection viscosupplements frequently offer quicker relief from joint pain and stiffness than multi-injection regimens. Patients looking for immediate symptom alleviation may find this rapid onset intriguing.

In 2021, SEIKAGAKU CORPORATION (via TCM Biotech International Corp.) announced the introduction of HyLink, an intra-articular single-injection viscosupplement for treating knee osteoarthritis, in Taiwan. A cross-linked hyaluronate hydrogel, produced with the specialized cross-linking technology of Seikagaku, serves as the primary component of HyLink. Such factors aided the business in diversifying its product offering.

Easy Access to a Pool of Doctors to Push Consumers towards Hospitals

Based on the end user, the hospital segment is anticipated to take up a significant regional market share. The hospital segment is expected to experience a 7.9% CAGR during the forecast period.

Hospitals offer cutting-edge medical infrastructure and tools, which are crucial for safely and successfully providing viscosupplementation injections. Sterile environments, diagnostic equipment, and, if required, surgical facilities are all part of this infrastructure.

Orthopedic departments and competent healthcare specialists, such as orthopedic surgeons and rheumatologists, are common in hospitals. Hospitals are a popular location for viscosupplementation operations since these professionals are skilled in diagnosing and treating joint-related problems.

Competitive Landscape

The need for cryotherapy technologies is anticipated to increase in the Europe region as a result of major manufacturers using cutting-edge technology in their viscosupplementation production. Some of the prominent developments by the important companies in this domain are provided below.

Company Key Developments
Anika Therapeutics, Inc.
  • In 2022, Anika Therapeutics Inc. stated that CINGAL had been given the green light by Health Canada to be used as a medical device to treat knee osteoarthritis (OA)-related pain.
  • Their unique cross-linked sodium hyaluronate (now sold as the single-injection viscosupplement MONOVISC) and triamcinolone hexacetonide, an FDA-approved steroid for the management of inflammation, are combined in CINGAL, the initial and sole combination viscosupplement to get approval.
Sanofi S.A.
  • In 2022, Sanofi S.A., and IGM Bioscience finalized an exclusive global partnership agreement to develop, produce, and market IgM antibody agonists towards three oncology targets along with three immunology/inflammation targets.
  • IgM antibodies are a novel class of potential treatments because they combine the multi-valency of IgM antibodies, which have 10 target binding sites as opposed to the two target binding sites found in traditional IgG antibodies.
Juniper Biologics
  • To develop and market TissueGene-C low dosage (TG-C LD), a non-surgical experimental treatment given as a single intra-articular injection for knee osteoarthritis, the company entered into a licensing agreement with Kolon Life Sciences.
  • In accordance with the licensing agreement, Juniper will create and promote gene therapy to hospitals and healthcare providers in Asia-Pacific, the Middle East, and Africa.

Report Scope

Attribute Details
Projected market value in 2023 US$ 4.91 billion
Projected market value in 2033 US$ 12.03 billion
Forecast CAGR from 2023 to 2033 5.8%
Forecast period 2023 to 2033
Historical period 2018 to 2022
Market analysis Value in US$ billion
Key Regions Covered
  • Western Europe
  • Eastern Europe
Key Countries Profiled
  • The United Kingdom
  • France
  • Germany
  • Spain
  • Italy
  • Nordics
  • Russia
Key market segments
  • Product
  • End user
  • Region
Key companies profiled
  • Anika Therapeutics Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings
  • Meda AB
  • Ferring B.V
  • Fidia Pharmaceutici S.p.A
  • Bioventus LLC
  • Teva Pharmaceutical Industries Ltd.
  • VIRCHOW BIOTECH
  • Lifecore Biomedical

Segmentation Analysis of the Europe Viscosupplementation Market

By Product:

  • Single Injection
  • Three Injection
  • Five Injection

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics

By Region:

  • Western Europe
  • Eastern Europe

Frequently Asked Questions

What is the anticipated market value of the Europe viscosupplementation market in 2023?

The Europe viscosupplementation market is expected to reach US$ 4.91 billion by 2023.

What is the expected CAGR for the Europe viscosupplementation market until 2033?

The Europe viscosupplementation market is set to expand by a CAGR of 9.37% by 2033.

What is the anticipated valuation of the market in 2033?

The Europe viscosupplementation industry is forecast to reach US$ 12.03 billion by 2033.

Which product type is likely to dominate the Europe viscosupplementation market?

A CAGR of 8.2% is anticipated for single injection viscosupplementation throughout the predicted period.

Which is the leading end user of the Europe viscosupplementation domain?

The hospitals sector is anticipated to grow at a 7.9% CAGR during the projected period.

Table of Content

1. Executive Summary

    1.1. Europe Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Single Injection Viscosupplementation

        5.3.2. Three Injection Viscosupplementation

        5.3.3. Five Injection Viscosupplementation

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Ambulatory Surgical Centres

        6.3.3. Orthopaedic Clinics

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. Western Europe

        7.3.2. Eastern Europe

    7.4. Market Attractiveness Analysis By Region

8. Western Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. UK

            8.2.1.2. France

            8.2.1.3. Germany

            8.2.1.4. Spain

            8.2.1.5. Italy

            8.2.1.6. Nordics

            8.2.1.7. Rest of Western Europe

        8.2.2. By Product Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Eastern Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Russia

            9.2.1.2. Rest of Eastern Europe

        9.2.2. By Product Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Market Structure Analysis

    10.1. Competition Dashboard

    10.2. Competition Benchmarking

    10.3. Market Share Analysis of Top Players

        10.3.1. By Regional

        10.3.2. By Product Type

        10.3.3. By End User

11. Competition Analysis

    11.1. Competition Deep Dive

        11.1.1. Anika Therapeutics Inc.

            11.1.1.1. Overview

            11.1.1.2. Product Portfolio

            11.1.1.3. Profitability by Market Segments

            11.1.1.4. Sales Footprint

            11.1.1.5. Strategy Overview

                11.1.1.5.1. Marketing Strategy

        11.1.2. Sanofi S.A.

            11.1.2.1. Overview

            11.1.2.2. Product Portfolio

            11.1.2.3. Profitability by Market Segments

            11.1.2.4. Sales Footprint

            11.1.2.5. Strategy Overview

                11.1.2.5.1. Marketing Strategy

        11.1.3. Zimmer Biomet Holdings

            11.1.3.1. Overview

            11.1.3.2. Product Portfolio

            11.1.3.3. Profitability by Market Segments

            11.1.3.4. Sales Footprint

            11.1.3.5. Strategy Overview

                11.1.3.5.1. Marketing Strategy

        11.1.4. Meda AB

            11.1.4.1. Overview

            11.1.4.2. Product Portfolio

            11.1.4.3. Profitability by Market Segments

            11.1.4.4. Sales Footprint

            11.1.4.5. Strategy Overview

                11.1.4.5.1. Marketing Strategy

        11.1.5. Ferring B.V

            11.1.5.1. Overview

            11.1.5.2. Product Portfolio

            11.1.5.3. Profitability by Market Segments

            11.1.5.4. Sales Footprint

            11.1.5.5. Strategy Overview

                11.1.5.5.1. Marketing Strategy

        11.1.6. Fidia Pharmaceutici S.p.A

            11.1.6.1. Overview

            11.1.6.2. Product Portfolio

            11.1.6.3. Profitability by Market Segments

            11.1.6.4. Sales Footprint

            11.1.6.5. Strategy Overview

                11.1.6.5.1. Marketing Strategy

        11.1.7. Bioventus LLC

            11.1.7.1. Overview

            11.1.7.2. Product Portfolio

            11.1.7.3. Profitability by Market Segments

            11.1.7.4. Sales Footprint

            11.1.7.5. Strategy Overview

                11.1.7.5.1. Marketing Strategy

        11.1.8. Teva Pharmaceutical Industries Ltd.

            11.1.8.1. Overview

            11.1.8.2. Product Portfolio

            11.1.8.3. Profitability by Market Segments

            11.1.8.4. Sales Footprint

            11.1.8.5. Strategy Overview

                11.1.8.5.1. Marketing Strategy

        11.1.9. VIRCHOW BIOTECH

            11.1.9.1. Overview

            11.1.9.2. Product Portfolio

            11.1.9.3. Profitability by Market Segments

            11.1.9.4. Sales Footprint

            11.1.9.5. Strategy Overview

                11.1.9.5.1. Marketing Strategy

        11.1.10. Lifecore Biomedical

            11.1.10.1. Overview

            11.1.10.2. Product Portfolio

            11.1.10.3. Profitability by Market Segments

            11.1.10.4. Sales Footprint

            11.1.10.5. Strategy Overview

                11.1.10.5.1. Marketing Strategy

12. Assumptions & Acronyms Used

13. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 3: Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 4: Western Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 5: Western Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 6: Western Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 7: Eastern Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: Eastern Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 9: Eastern Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 2: Market Value (US$ Million) by End User, 2023 to 2033

Figure 3: Market Value (US$ Million) by Region, 2023 to 2033

Figure 4: Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 6: Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 7: Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 8: Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 9: Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 10: Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 11: Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 12: Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 13: Market Attractiveness by Product Type, 2023 to 2033

Figure 14: Market Attractiveness by End User, 2023 to 2033

Figure 15: Market Attractiveness by Region, 2023 to 2033

Figure 16: Western Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 17: Western Market Value (US$ Million) by End User, 2023 to 2033

Figure 18: Western Market Value (US$ Million) by Country, 2023 to 2033

Figure 19: Western Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 20: Western Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 21: Western Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 22: Western Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 23: Western Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 24: Western Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 25: Western Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 26: Western Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 27: Western Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 28: Western Market Attractiveness by Product Type, 2023 to 2033

Figure 29: Western Market Attractiveness by End User, 2023 to 2033

Figure 30: Western Market Attractiveness by Country, 2023 to 2033

Figure 31: Eastern Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 32: Eastern Market Value (US$ Million) by End User, 2023 to 2033

Figure 33: Eastern Market Value (US$ Million) by Country, 2023 to 2033

Figure 34: Eastern Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 35: Eastern Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 36: Eastern Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 37: Eastern Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 38: Eastern Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 39: Eastern Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 40: Eastern Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 41: Eastern Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 42: Eastern Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 43: Eastern Market Attractiveness by Product Type, 2023 to 2033

Figure 44: Eastern Market Attractiveness by End User, 2023 to 2033

Figure 45: Eastern Market Attractiveness by Country, 2023 to 2033

Explore Healthcare Insights

View Reports

Europe Viscosupplementation Market